BIOQuébec has spoken out several times in recent years in favour of effective changes to the regulatory framework governing drug pricing in Canada. This is an extremely important issue for the development of the life sciences sector, in a context where medical advances are accelerating and taking on a global scope. Canadians cannot afford to see their economy left behind in this technological revolution as a result of misguided public policies that undermine the significant investments made by both the private and public sectors.
Read MoreNearly 120 individual companies took the time to respond to this survey - that's huge and very representative of our industry. This report contains important recommendations based on the responses we received.
Read MoreThe following recommendations were submitted to the Minister of Finance and to the Minister of the Economy, Science, and Innovation. Their objective is to foster the growth of innovative businesses, facilitate their integration, support innovation, and recognize the contributions of the life sciences industry.
Read MoreAs part of the pre-budget consultations, BIOQuébec submitted its recommendations to Québec’s Minister of Finance for the 2016-2017 budget.
Read More